Reply:

References

1. 1.↵
   2. Karia SJ,
   3. Rykken JB,
   4. McKinney ZJ, et al

   . Utility and significance of gadolinium-based contrast enhancement in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 2016;37:415–22 doi:10.3174/ajnr.A4563 pmid:26564441

   Abstract/FREE Full Text
2. 2.↵
   2. McKinney AM,
   3. Short J,
   4. Truwit CL, et al

   . Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR Am J Roentgenol 2007;189:904–12 doi:10.2214/AJR.07.2024 pmid:17885064

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Covarrubias DJ,
   3. Luetmer PH,
   4. Campeau NG

   . Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. AJNR Am J Neuroradiol 2002;23:1038–48 pmid:12063238

   Abstract/FREE Full Text
4. 4.↵
   2. Ay H,
   3. Buonanno FS,
   4. Schaefer PW, et al

   . Posterior leukoencephalopathy without severe hypertension: utility of diffusion-weighted MRI. Neurology 1998;51:1369–76 doi:10.1212/WNL.51.5.1369 pmid:9818862

   Abstract/FREE Full Text
5. 5.↵
   2. Gao B,
   3. Yu BX,
   4. Li RS, et al

   . Cytotoxic edema in posterior reversible encephalopathy syndrome: correlation of MRI features with serum albumin levels. AJNR Am J Neuroradiol 2015;36:1884–89 doi:10.3174/ajnr.A4379 pmid:26138140

   Abstract/FREE Full Text
6. 6.↵
   2. McKinney AM,
   3. Sarikaya B,
   4. Gustafson C, et al

   . Detection of microhemorrhage in posterior reversible encephalopathy syndrome using susceptibility-weighted imaging. AJNR Am J Neuroradiol 2012;33:896–903 doi:10.3174/ajnr.A2886 pmid:22241378

   Abstract/FREE Full Text
7. 7.↵
   2. Legriel S,
   3. Schraub O,
   4. Azoulay E, et al

   . Determinants of recovery from severe posterior reversible encephalopathy syndrome. PLoS One 2012;7:e44534 doi:10.1371/journal.pone.0044534 pmid:23024751

   CrossRefPubMed